Evaxion Biotech AS is a clinical-stage biotech company that aspires to the exploration of artificial intelligence, or AI, to develop immunotherapies with improved efficacy when compared to currently marketed products for patients with unmet medical needs. Its pipeline programs are derived from its proprietary AI platforms, PIONEER, EDEN, RAVEN, and ObsERV. The company is utilizing these AI platforms to build a drug development pipeline. Its product candidates are; EVX-01 and EVX-02, for the treatment of various cancers, and the third candidate is cancer immunotherapy, EVX-03, for the treatment of various cancers including non-small-cell-lung-cancer, or NSCLC, is in pre-clinical development.
This is not a financial advice!
Upcoming catalysts on 09/30 2024 and 12/31/2024
Shs. Float of 2.91M
This could be a slower play. Don't expect a fast move. But i see lots of potential in this company.
We need to stay in a bullish overal sentiment of the market. If we see a corretion, this play might doesn't work.
Keep an eye on 5.3/ 5.7/ 7.0 levels, needs to get broken for a further upmove. You can take partial profits at these levels if u want to lock in gains.
SL under 2.5
TPs approx. 9.0 or even 13
Most info on the chart.
Trade carefully!
This is not a financial advice!
Upcoming catalysts on 09/30 2024 and 12/31/2024
Shs. Float of 2.91M
This could be a slower play. Don't expect a fast move. But i see lots of potential in this company.
We need to stay in a bullish overal sentiment of the market. If we see a corretion, this play might doesn't work.
Keep an eye on 5.3/ 5.7/ 7.0 levels, needs to get broken for a further upmove. You can take partial profits at these levels if u want to lock in gains.
SL under 2.5
TPs approx. 9.0 or even 13
Most info on the chart.
Trade carefully!
Comment:
Evaxion: An Intriguing AI Vaccine Company With Big Pharma Collaboration
Comment:
Ladenburg Thalmann Upgrades Evaxion Biotech to Buy, Announces $8 Price Target